Related Experiment Video

Updated: Jun 22, 2026

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

Anesthesia in Guillain-Barré pediatric patient after measles vaccination. Case report

Deoclécio Tonelli1, Paula de Camargo Neves Sacco, Desire Calegari

  • 1CET Integrado de Anestesia da Faculdade de Medicina ABC, Santo André, SP.

Revista Brasileira De Anestesiologia
|May 27, 2009
PubMed

Insights

Guillain-Barré syndrome after measles vaccination is rare but can cause serious complications. This case report details anesthetic management for a pediatric patient with advanced Guillain-Barré syndrome.

Area of Science:

  • Pediatric Neurology
  • Anesthesiology
  • Vaccine Safety

Background:

  • Guillain-Barré syndrome (GBS) following measles vaccination is an infrequent but significant adverse event.
  • Delayed diagnosis of GBS can lead to increased patient morbidity.
  • This report focuses on a pediatric case with advanced GBS.

Purpose of the Study:

  • To describe an advanced pediatric case of Guillain-Barré syndrome.
  • To outline specialized anesthetic approaches for managing GBS patients.
  • To emphasize the importance of recognizing GBS in anesthetic practice.

Main Methods:

  • A case report of a 4-year-old male diagnosed with Guillain-Barré syndrome at 1 year of age.
  • The patient underwent a gastrostomy procedure.
  • General anesthesia was administered using sevoflurane without neuromuscular blockers.

Main Results:

  • The gastrostomy procedure under general anesthesia was uneventful.
  • The anesthetic management avoided neuromuscular blockers, indicating a successful approach for this GBS patient.
  • The case underscores the challenges in diagnosing GBS, particularly post-vaccination.

Conclusions:

  • Highlights the underdiagnosis of Guillain-Barré syndrome, especially in the context of post-vaccination adverse events.
  • Discusses optimal anesthetic strategies for pediatric patients with GBS.
  • Addresses potential complications associated with pediatric Guillain-Barré syndrome.
Abstract

Related Concept Videos

Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...